COH Relative Valuation - Cochlear Ltd

Watchlist Manager

Watchlist

Price: 166.49 AUD -3.44% Market Closed

Market Cap: AU$10.9B

Relative Value

The Relative Value of one COH stock under the Base Case scenario is hidden AUD. Compared to the current market price of 166.49 AUD, Cochlear Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

COH Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

		Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
AU	Cochlear Ltd ASX:COH	10.9B AUD	4.7	31.5	21.7	21.7
US	Abbott Laboratories NYSE:ABT	187.8B USD	4.2	28.7	16.4	22.6
US	Intuitive Surgical Inc NASDAQ:ISRG	169.4B USD	16.9	59.7	45.3	55.6
US	Stryker Corp NYSE:SYK	130.5B USD	5.2	40.3	20.6	24.9
IE	Medtronic PLC NYSE:MDT	111.4B USD	3.1	24.2	13.4	19.5
US	Boston Scientific Corp NYSE:BSX	105.4B USD	5.2	36.2	21.2	28.5
DE	Siemens Healthineers AG XETRA:SHL	42.2B EUR	1.8	19.9	11.2	15.7
US	Edwards Lifesciences Corp NYSE:EW	48B USD	8	45	24.8	27.1
US	IDEXX Laboratories Inc NASDAQ:IDXX	46B USD	10.8	43.7	31	34.3
US	Becton Dickinson and Co NYSE:BDX	44.9B USD	2.1	25.7	10.1	17.1
US	Resmed Inc NYSE:RMD	33.1B USD	6.2	22.4	15.7	17.5

			Revenue Growth	P/S to Growth
AU	Cochlear Ltd ASX:COH	Average P/S: 6.2 4.7	8%	0.6
US	Abbott Laboratories NYSE:ABT	4.2	8%	0.5
US	Intuitive Surgical Inc NASDAQ:ISRG	16.9	15%	1.1
US	Stryker Corp NYSE:SYK	5.2	9%	0.6
IE	Medtronic PLC NYSE:MDT	3.1	7%	0.4
US	Boston Scientific Corp NYSE:BSX	5.2	11%	0.5
DE	Siemens Healthineers AG XETRA:SHL	1.8	5%	0.4
US	Edwards Lifesciences Corp NYSE:EW	8	11%	0.7
US	IDEXX Laboratories Inc NASDAQ:IDXX	10.8	10%	1.1
US	Becton Dickinson and Co NYSE:BDX	2.1	-2%	N/A
US	Resmed Inc NYSE:RMD	6.2	8%	0.8

			Earnings Growth	PEG
AU	Cochlear Ltd ASX:COH	Average P/E: 34.3 31.5	11%	2.9
US	Abbott Laboratories NYSE:ABT	28.7	23%	1.2
US	Intuitive Surgical Inc NASDAQ:ISRG	59.7	19%	3.1
US	Stryker Corp NYSE:SYK	40.3	30%	1.3
IE	Medtronic PLC NYSE:MDT	24.2	22%	1.1
US	Boston Scientific Corp NYSE:BSX	36.2	31%	1.2
DE	Siemens Healthineers AG XETRA:SHL	19.9	16%	1.2
US	Edwards Lifesciences Corp NYSE:EW	45	27%	1.7
US	IDEXX Laboratories Inc NASDAQ:IDXX	43.7	13%	3.4
US	Becton Dickinson and Co NYSE:BDX	25.7	35%	0.7
US	Resmed Inc NYSE:RMD	22.4	11%	2

			EBITDA Growth	EV/EBITDA to Growth
AU	Cochlear Ltd ASX:COH	Average EV/EBITDA: 21 21.7	16%	1.4
US	Abbott Laboratories NYSE:ABT	16.4	11%	1.5
US	Intuitive Surgical Inc NASDAQ:ISRG	45.3	23%	2
US	Stryker Corp NYSE:SYK	20.6	12%	1.7
IE	Medtronic PLC NYSE:MDT	13.4	8%	1.7
US	Boston Scientific Corp NYSE:BSX	21.2	18%	1.2
DE	Siemens Healthineers AG XETRA:SHL	11.2	10%	1.1
US	Edwards Lifesciences Corp NYSE:EW	24.8	14%	1.8
US	IDEXX Laboratories Inc NASDAQ:IDXX	31	11%	2.8
US	Becton Dickinson and Co NYSE:BDX	10.1	1%	10.1
US	Resmed Inc NYSE:RMD	15.7	11%	1.4

			EBIT Growth	EV/EBIT to Growth
AU	Cochlear Ltd ASX:COH	Average EV/EBIT: 25.9 21.7	11%	2
US	Abbott Laboratories NYSE:ABT	22.6	18%	1.3
US	Intuitive Surgical Inc NASDAQ:ISRG	55.6	25%	2.2
US	Stryker Corp NYSE:SYK	24.9	16%	1.6
IE	Medtronic PLC NYSE:MDT	19.5	17%	1.1
US	Boston Scientific Corp NYSE:BSX	28.5	26%	1.1
DE	Siemens Healthineers AG XETRA:SHL	15.7	15%	1
US	Edwards Lifesciences Corp NYSE:EW	27.1	15%	1.8
US	IDEXX Laboratories Inc NASDAQ:IDXX	34.3	12%	2.9
US	Becton Dickinson and Co NYSE:BDX	17.1	15%	1.1
US	Resmed Inc NYSE:RMD	17.5	12%	1.5

Cochlear Ltd
ASX:COH

Relative Value

Valuation Multiples

Multiples Across Competitors

COH Competitors Multiples
Cochlear Ltd Competitors

See Also

Company

Help

Tools

Stocks

Cochlear Ltd ASX:COH

Relative Value

Valuation Multiples

Multiples Across Competitors

COH Competitors Multiples Cochlear Ltd Competitors

See Also

Company

Help

Tools

Stocks

Cochlear Ltd
ASX:COH

COH Competitors Multiples
Cochlear Ltd Competitors